Ledger.Open graph →
SEC Form D · filed December 23, 2013

Kinex Pharmaceuticals, Inc

Offering
$40.0M
Sold
$300K
Exemption
Rule 506(b)
Industry
Biotechnology
Location
BUFFALO, NY
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (13)

Flint Besecker · Orchard Park, NYExec · DirectorJean-Pierre Sommadossi · Boston, MADirectorLyn Dyster · Lewiston, NYExecDavid Hangauer · Lancaster, NYExecJohnson Lau · Newport Beach, CAExec · DirectorJinn Wu · Princeton Junction, NJDirectorIan F. Goodall · Camana Bay, Cayman IslandsDirectorCrestwood Capital Group, LLC · New York, NYExec · DirectorCohn Cohn · Menlo Park, CADirectorJames Mccormick · Fremont, CAExecKevin C. Eichler · Fremont, CAExecTom Trometer · Lincoln, MAExec · DirectorGrant Jackson · Grand Cayman, Cayman IslandsDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗